Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7.

Nat Commun · 2023 · PMC10491676 · PMID 37684239

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This resulted in highly significant inhibition of tumour growth (mean size ± SEM 4.90 ± 1.11 mm 2 ) compared to mice receiving untransduced T cells (67.23 ± 6.30 mm 2 ) at d27 post-tumour injection (Fig. 7a ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.